Phase 1/1B Study in Patients With Cancer KRYSTAL 14

Phase 1/1B Study in Patients With Cancer KRYSTAL 14
Conditions:   Advanced Cancer;   Metastatic Cancer;   Malignant Neoplasm of Colon;   Malignant Neoplasm of Lung;   Malignant Neoplastic Disease
Interventions:   Drug: MRTX849;   Drug: BI 1701963
Sponsors:   Mirati Therapeutics Inc.;   Boehringer Ingelheim
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 24, 2021Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments